Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Beyond Air, Inc. (XAIR)
USD5.67
-0.10 (-1.73%)
US NASDAQ Healthcare Medical - Devices
Address
900 Stewart Avenue 11530
Garden City, NY, US
Garden City, NY, US
CEO
Amir Avniel
Website
beyondair.net
IPO
2018-06-12
CIK 1641631 ISIN US08862L2025
Description
Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an innovative system that generates and delivers nitric oxide. Within this platform, LungFit PH is currently available, used to address persistent pulmonary hypertension in infants. Furthermore, the company is advancing LungFit PRO, a product intended for various viral lung ailments like community-acquired viral pneumonia (including COVID-19) and bronchiolitis in hospital settings. It is also creating LungFit GO, which aims to treat nontuberculous mycobacteria infections. The organization adopted its current name, Beyond Air, Inc., in June 2019, having previously been known as AIT Therapeutics, Inc. Its headquarters are situated in Garden City, New York.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD5.67
-0.10 (-1.73%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
340.0K
Beta
0.23
Float Shares
4.78M
Free Float %
94.2%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.37% | +12.03% | -12.41% | -52.14% | -65.93% | -36.64% | -87.53% | -99.56% | -99.53% | -99.60% | -99.60% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (7 ratings, all time)
Buy
Price Targets & DCF
Current price
5.67
Low
1.00
-82.4%
Consensus
1.00
-82.4%
Median
1.00
-82.4%
High
1.00
-82.4%
Ratings Trend (MoM)
75% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 1 |
1.00
-82.4%
|
Quality scores
Altman Z-Score
-13.49
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%+107.3% ★ Q1'26: +65.5% (vs Q1'25)
-
EPS growth Medical - Devices: +28.5%+70.9% ★ Q1'26: +66.5% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%-318.3% Q1'26: -288.0% (vs Q1'25)
-
EBIT margin Medical - Devices: +6.2%+0.0% Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Devices: +3.3%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+145.2% Q1'26: +84.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.06× Q1'26: -0.10× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 2 Rev. Ana. 2 EPS Ana. |
Mar 2027 2 Rev. Ana. 2 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
Mar 2029 1 Rev. Ana. 1 EPS Ana. |
Mar 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
7.72M
est: 6.63M (+16.6%)
|
1.39M
est: 1.90M (-26.8%)
|
873.0K
est: 965.6K (-9.6%)
|
—
est: 526.0K (-100.0%)
|
1.16M
est: 1.78M (-35.0%)
|
3.71M
est: 3.91M (-5.2%)
|
8.08M
7.97M – 8.19M
+106.6% YoY
|
12.60M
12.44M – 12.78M
+56.0% YoY
|
30.60M
30.20M – 31.03M
+142.8% YoY
|
59.58M
58.81M – 60.42M
+94.7% YoY
|
75.94M
74.96M – 77.02M
+27.5% YoY
|
| EBITDA |
-6.49M
est: -1.32M (-390.1%)
|
-19.91M
est: -379.7K (-5,142.8%)
|
-22.02M
est: -193.1K (-11,303.3%)
|
-58.20M
est: -105.2K (-55,224.7%)
|
-59.03M
est: -356.6K (-16,453.9%)
|
-41.89M
est: -782.0K (-5,256.4%)
|
-1.62M
-1.64M – -1.59M
-106.6% YoY
|
-2.52M
-2.56M – -2.49M
-56.0% YoY
|
-6.12M
-6.21M – -6.04M
-142.8% YoY
|
-11.92M
-12.08M – -11.76M
-94.7% YoY
|
-15.19M
-15.40M – -14.99M
-27.5% YoY
|
| EBIT |
-6.56M
est: -1.32M (-394.9%)
|
-20.07M
est: -379.7K (-5,184.8%)
|
-22.23M
est: -193.1K (-11,412.6%)
|
-59.37M
est: -105.2K (-56,336.8%)
|
-61.38M
est: -356.6K (-17,113.5%)
|
-45.46M
est: -782.0K (-5,713.0%)
|
-1.62M
-1.64M – -1.59M
-106.6% YoY
|
-2.52M
-2.56M – -2.49M
-56.0% YoY
|
-6.12M
-6.21M – -6.04M
-142.8% YoY
|
-11.92M
-12.08M – -11.76M
-94.7% YoY
|
-15.19M
-15.40M – -14.99M
-27.5% YoY
|
| Net Income |
-6.56M
est: -31.37M (+79.1%)
|
-19.94M
est: -123.23M (+83.8%)
|
-22.88M
est: -90.32M (+74.7%)
|
-55.82M
est: -113.44M (+50.8%)
|
-60.24M
est: -13.18M (-357.2%)
|
-46.63M
est: -122.48M (+61.9%)
|
-31.35M
-31.90M – -30.80M
+74.4% YoY
|
-14.37M
-14.63M – -14.12M
+54.2% YoY
|
-9.55M
-9.72M – -9.39M
+33.5% YoY
|
-2.24M
-2.28M – -2.20M
+76.5% YoY
|
-3.57M
-3.64M – -3.51M
-59.1% YoY
|
| SGA |
6.85M
est: 70.53M (-90.3%)
|
8.88M
est: 20.21M (-56.0%)
|
10.47M
est: 10.28M (+1.8%)
|
34.69M
est: 5.60M (+519.6%)
|
37.34M
est: 15.59M (+139.5%)
|
26.02M
est: 34.19M (-23.9%)
|
70.63M
69.72M – 71.63M
+106.6% YoY
|
110.17M
108.75M – 111.73M
+56.0% YoY
|
267.51M
264.07M – 271.31M
+142.8% YoY
|
520.91M
514.20M – 528.31M
+94.7% YoY
|
664.00M
655.45M – 673.43M
+27.5% YoY
|
| EPS |
-15.43
est: -9.27 (-66.6%)
|
-35.57
est: -36.40 (+2.3%)
|
-25.41
est: -26.68 (+4.8%)
|
-37.24
est: -33.50 (-11.2%)
|
-36.33
est: -1.59 (-2,190.7%)
|
-13.77
est: -14.84 (+7.2%)
|
-3.77
-3.84 – -3.71
+74.6% YoY
|
-1.73
-1.76 – -1.70
+54.2% YoY
|
-1.15
-1.17 – -1.13
+33.5% YoY
|
-0.27
-0.27 – -0.27
+76.5% YoY
|
-0.43
-0.44 – -0.42
-59.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-26 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-19 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-18 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-15 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C- | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-11.79M
OE per share TTM
-2.32
Owner's Yield
-297.53%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
265.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
28
Total invested
966.1K
Insider transactions (90d)
0
Beneficial owners (>5%)
24
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Avenue Capital Management II, L.P. | 13.62M | 14.30% | 13.62M | — | 13.62M | — | OO | Delaware | 2024-10-09 | ↗ |
| 2 | GL Venture Opportunities Partners, LLC | 8.17M | 8.60% | — | — | — | — | OO | Delaware | 2024-10-09 | ↗ |
| 3 | L.P. | 8.17M | 8.60% | — | — | — | — | OO | Delaware | 2024-10-09 | ↗ |
| 4 | Marc Lasry | 8.17M | 8.60% | — | — | — | — | OO | Delaware | 2024-10-09 | ↗ |
| 5 | Avenue Venture Opportunities Partners, LLC | 5.60M | 5.90% | — | — | — | — | OO | Delaware | 2024-10-03 | ↗ |
| 6 | Avenue Venture Opportunities Fund, L.P. | 5.45M | 5.70% | — | — | — | — | OO | Delaware | 2024-10-09 | ↗ |
| 7 | Avenue Venture Opportunities Partners II, LLC | 5.45M | 5.70% | — | — | — | — | OO | Delaware | 2024-10-09 | ↗ |
| 8 | GL Venture Opportunities Partners II, LLC | 5.45M | 5.70% | — | — | — | — | OO | Delaware | 2024-10-09 | ↗ |
| 9 | Charles Mosseri Marlio | 2.31M | 7.76% | 2.31M | — | 2.31M | — | IN | France | 2022-02-09 | ↗ |
| 10 | Marlio | 1.98M | 9.60% | 1.98M | — | 1.98M | — | IN | United Kingdom | 2021-05-04 | ↗ |
| 11 | (1) BlackRock, Inc. | 1.86M | 5.80% | 1.84M | — | 1.86M | — | HC | Delaware | 2024-01-29 | ↗ |
| 12 | (1)Names of reporting persons. BlackRock, Inc. | 1.79M | 4.96% | 1.77M | — | 1.79M | — | HC | Delaware | 2024-03-07 | ↗ |
| 13 | ALLIANZ GLOBAL INVESTORS U.S. HOLDINGS LLC | 889.2K | 9.99% | — | — | — | — | HC, OO | Delaware | 2019-02-13 | ↗ |
| 14 | Fund, L.P. | 856.9K | 9.12% | — | 856.9K | — | — | PN | Delaware | 2019-02-12 | ↗ |
| 15 | Company, L.P. | 833.3K | 3.03% | — | 833.3K | — | — | PN | Delaware | 2022-02-11 | ↗ |
| 16 | Deerfield Mgmt, L.P. | 833.3K | 3.03% | — | 833.3K | — | — | PN | Delaware | 2022-02-11 | ↗ |
| 17 | Deerfield Partners, L.P. | 833.3K | 3.03% | — | 833.3K | — | — | PN | Delaware | 2022-02-11 | ↗ |
| 18 | James E. Flynn | 833.3K | 3.03% | — | 833.3K | — | — | IN | United States | 2022-02-11 | ↗ |
| 19 | U.S. HOLDINGS LLC | 745.3K | 10.90% | — | — | — | — | OO | Delaware | 2018-03-09 | ↗ |
| 20 | ALLIANZ GLOBAL INVESTORS GMBH | 676.5K | 7.60% | 676.5K | — | 676.5K | — | IA, OO | Delaware | 2019-02-13 | ↗ |
| 21 | GMBH | 621.4K | 9.30% | 621.4K | — | 621.4K | — | OO | Delaware | 2018-03-09 | ↗ |
| 22 | Kingdon Capital Management, L.L.C. | 500.0K | 7.78% | — | 500.0K | — | 500.0K | IA | Delaware | 2018-02-14 | ↗ |
| 23 | M. Kingdon Offshore Master Fund L.P. | 500.0K | 7.78% | — | 500.0K | — | 500.0K | PN | Delaware | 2018-02-14 | ↗ |
| 24 | Mark Kingdon | 500.0K | 7.78% | — | 500.0K | — | 500.0K | HC, IN | Delaware | 2018-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
28
+1 vs prev Q
New positions
6
Closed positions
5
Increased
8
Reduced
9
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ALYESKA INVESTMENT GROUP, L.P. | 582.6K -176.4K (-23.2%) | 423.0K -1.3M (-75.9%) | 9.17% -2.775 pp | 0.00% -0.004 pp | USD2.31 -68.4% | 2 qtrs — |
| 2 | BALYASNY ASSET MANAGEMENT L.P. | 464.2K +— (+0.0%) | 337.0K -735.2K (-68.6%) | 7.30% +0.000 pp | 0.00% -0.001 pp | USD2.31 -68.4% | 2 qtrs — |
| 3 | BLEICHROEDER LP | 86.5K +— (+0.0%) | 62.8K -137.0K (-68.6%) | 1.36% +0.000 pp | 0.01% -0.028 pp | USD2.31 -68.4% | 2 qtrs — |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 67.7K +24.7K (+57.5%) | 49.1K -50.2K (-50.5%) | 0.79% +0.109 pp | 0.00% +0.000 pp | USD1.73 -57.8% | 2 qtrs — |
| 5 | VANGUARD GROUP INC | 60.4K -44.0K (-42.1%) | 43.9K -197.3K (-81.8%) | 0.70% -0.941 pp | 0.00% +0.000 pp | USD2.31 -68.4% | 2 qtrs — |
| 6 | JANE STREET GROUP, LLC | 33.3K +33.3K (+100.0%) | 24.2K +24.2K (+100.0%) | 0.39% +0.387 pp | 0.00% +0.000 pp | USD0.73 +0.0% | 1 qtrs NEW |
| 7 | WEALTH EFFECTS LLC | 31.7K -2.1K (-6.1%) | 23.0K -55.0K (-70.5%) | 0.50% -0.033 pp | 0.01% -0.018 pp | USD2.31 -68.4% | 2 qtrs — |
| 8 | BLACKROCK, INC. | 22.0K +— (+0.0%) | 16.0K -34.9K (-68.6%) | 0.26% -0.091 pp | 0.00% +0.000 pp | USD2.31 -68.4% | 2 qtrs — |
| 9 | XTX TOPCO LTD | 18.2K +18.2K (+100.0%) | 13.2K +13.2K (+100.0%) | 0.21% +0.211 pp | 0.00% +0.000 pp | USD0.73 +0.0% | 1 qtrs NEW |
| 10 | VIRTU FINANCIAL LLC | 12.2K -8.7K (-41.7%) | 9.0K -39.0K (-81.3%) | 0.14% -0.187 pp | 0.00% -0.002 pp | USD2.31 -68.4% | 2 qtrs — |
| 11 | ADVISOR GROUP HOLDINGS, INC. | 8.1K +— (+0.0%) | 5.9K -14.0K (-70.2%) | 0.09% -0.034 pp | 0.00% +0.000 pp | USD2.31 -68.4% | 2 qtrs — |
| 12 | TOWER RESEARCH CAPITAL LLC (TRC) | 7.4K +7.4K (+100.0%) | 5.4K +5.4K (+100.0%) | 0.09% +0.086 pp | 0.00% +0.000 pp | USD0.73 +0.0% | 1 qtrs NEW |
| 13 | PFS PARTNERS, LLC | 2.0K +— (+0.0%) | 1.5K -3.2K (-68.6%) | 0.03% +0.000 pp | 0.00% -0.002 pp | USD2.31 -68.4% | 2 qtrs — |
| 14 | IFP ADVISORS, INC | 1.1K +1.1K (+100.0%) | 825.00 +825.0 (+100.0%) | 0.01% +0.013 pp | 0.00% +0.000 pp | USD0.73 +0.0% | 1 qtrs NEW |
| 15 | GROUP ONE TRADING, L.P. | 615.00 -41.0 (-6.3%) | 446.00 -1.1K (-70.6%) | 0.01% -0.003 pp | 0.00% +0.000 pp | USD2.31 -68.4% | 2 qtrs — |
| 16 | FORTITUDE FAMILY OFFICE, LLC | 603.00 +603.0 (+100.0%) | 438.00 +438.0 (+100.0%) | 0.01% +0.007 pp | 0.00% +0.000 pp | USD0.72 +1.4% | 1 qtrs NEW |
| 17 | MAI CAPITAL MANAGEMENT | 500.00 +— (+0.0%) | 363.00 -792.0 (-68.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD2.31 -68.4% | 2 qtrs — |
| 18 | NEWEDGE ADVISORS, LLC | 457.00 +— (+0.0%) | 332.00 -724.0 (-68.6%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD2.31 -68.4% | 2 qtrs — |
| 19 | SBI SECURITIES CO., LTD. | 90.00 +— (+0.0%) | 65.00 -143.0 (-68.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD0.17 +329.4% | 3 qtrs — |
| 20 | BANK OF AMERICA CORP /DE/ | 68.00 -41.0 (-37.6%) | 49.00 -203.0 (-80.6%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.29 -68.1% | 2 qtrs — |
| 21 | GODSEY & GIBB, INC | 50.00 +— (+0.0%) | 37.00 -79.0 (-68.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.30 -68.3% | 2 qtrs — |
| 22 | MORGAN STANLEY | 50.00 +10.0 (+25.0%) | 36.00 -56.0 (-60.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.98 -63.1% | 2 qtrs — |
| 23 | BNP PARIBAS ARBITRAGE, SNC | 41.00 +— (+0.0%) | 30.00 -65.0 (-68.4%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.29 -68.1% | 2 qtrs — |
| 24 | JPMORGAN CHASE & CO | 32.00 +— (+0.0%) | 23.00 -51.0 (-68.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.28 -68.0% | 2 qtrs — |
| 25 | UBS GROUP AG | 10.00 +— (+0.0%) | 7.00 -16.0 (-69.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.30 -68.3% | 2 qtrs — |
| 26 | JONES FINANCIAL COMPANIES LLLP | 10.00 -82.0 (-89.1%) | 7.00 -219.0 (-96.9%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD2.30 -68.3% | 2 qtrs — |
| 27 | CITIGROUP INC | — -2.6K (-100.0%) | — -5.9K (-100.0%) | 0.00% -0.040 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 28 | KINGDON CAPITAL MANAGEMENT, L.L.C. | — -46.8K (-100.0%) | — -108.2K (-100.0%) | 0.00% -0.737 pp | 0.00% -0.013 pp | USD— | 2 qtrs SOLD |
| 29 | ALPINE GLOBAL MANAGEMENT, LLC | — -10.7K (-100.0%) | — -24.6K (-100.0%) | 0.00% -0.168 pp | 0.00% -0.004 pp | USD— | 2 qtrs SOLD |
| 30 | BALDWIN BROTHERS LLC/MA | — -15.4K (-100.0%) | — -35.6K (-100.0%) | 0.00% -0.242 pp | 0.00% -0.002 pp | USD— | 24 qtrs SOLD |
| 31 | ADVISORY SERVICES NETWORK, LLC | — -1.1K (-100.0%) | — -2.6K (-100.0%) | 0.00% -0.018 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 32 | WEALTHSPIRE ADVISORS, LLC | — -822.0 (-100.0%) | — -1.9K (-100.0%) | 0.00% -0.013 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 33 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | — -20.0 (-100.0%) | — -46.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 28.2K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
70.0K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+70,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-05 | MOORHEAD DANIEL J | Officer | A-Award | A | Stock Option (right to buy) | 70,000 | 0.79 | 55.3K | 70,000 | D | ↗ |
| 2025-11-04 | Lucera Erick | Director | D-Return | D | Stock Options (Right to buy) | 1,250 | 10.80 | 13.5K | 0 | D | ↗ |
| 2025-11-04 | Lisi Steven A. | Director / Officer | A-Award | A | Stock Options (Right to buy) | 40,000 | 1.95 | 78.0K | 40,000 | D | ↗ |
| 2025-11-04 | Lee Yoori | Director | A-Award | A | Stock Options (Right to buy) | 3,750 | 1.95 | 7.3K | 3,750 | D | ↗ |
| 2025-11-04 | Larson Douglas Quinton | Officer | A-Award | A | Stock Options (Right to buy) | 6,000 | 1.95 | 11.7K | 6,000 | D | ↗ |
| 2025-11-04 | Goodman Robert Scott | Director | D-Return | D | Stock Options (Right to buy) | 187 | 10.80 | 2.0K | 0 | D | ↗ |
| 2025-11-04 | Gaul Michael A. | Officer | A-Award | A | Stock Options (Right to buy) | 1,250 | 1.95 | 2.4K | 1,250 | D | ↗ |
| 2025-11-04 | Forbes William P | Director | A-Award | A | Stock Options (Right to buy) | 3,750 | 1.95 | 7.3K | 3,750 | D | ↗ |
| 2025-11-04 | Carey Robert | Director | A-Award | A | Stock Options (Right to buy) | 10,000 | 1.95 | 19.5K | 10,000 | D | ↗ |
| 2025-11-03 | Lisi Steven A. | Director / Officer | D-Return | D | Warrants to purchase Common Stock | 164,778 | 7.59 | 1.25M | 0 | D | ↗ |
| 2025-11-03 | Carey Robert | Director | D-Return | D | Warrants to purchase Common Stock | 494,332 | 7.59 | 3.75M | 0 | D | ↗ |
| 2025-08-14 | Goodman Robert Scott | Director | A-Award | A | Stock Options (Right to buy) | 3,750 | 2.45 | 9.2K | 5,750 | D | ↗ |
| 2025-07-21 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 6,000 | 3.25 | 19.5K | 3,327,411 | D | ↗ |
| 2025-06-16 | Goodman Robert Scott | Director | — | — | Common Stock, par value $0.0001 per share | 0 | 0.00 | — | 40,000 | D | ↗ |
| 2025-03-26 | Lucera Erick | Director | A-Award | A | Stock Options (Right to buy) | 75,000 | 0.29 | 22.1K | 75,000 | D | ↗ |
| 2025-03-26 | Lisi Steven A. | Director / Officer | A-Award | A | Stock Options (Right to buy) | 950,000 | 0.29 | 279.9K | 950,000 | D | ↗ |
| 2025-03-26 | Lee Yoori | Director | A-Award | A | Stock Options (Right to buy) | 75,000 | 0.29 | 22.1K | 75,000 | D | ↗ |
| 2025-03-26 | Larson Douglas Quinton | Officer | A-Award | A | Stock Options (Right to buy) | 350,000 | 0.29 | 103.1K | 350,000 | D | ↗ |
| 2025-03-26 | Gaul Michael A. | Officer | A-Award | A | Stock Options (Right to buy) | 400,000 | 0.29 | 117.8K | 400,000 | D | ↗ |
| 2025-03-26 | Forbes William P | Director | A-Award | A | Stock Options (Right to buy) | 75,000 | 0.29 | 22.1K | 75,000 | D | ↗ |
| 2025-03-26 | Carey Robert | Director | A-Award | A | Stock Options (Right to buy) | 200,000 | 0.29 | 58.9K | 200,000 | D | ↗ |
| 2025-03-14 | Carey Robert | Director | P-Purchase | A | Common Stock | 990,000 | 0.25 | 247.5K | 4,066,864 | D | ↗ |
| 2025-02-19 | Gaul Michael A. | Officer | P-Purchase | A | Common Stock | 6,000 | 0.38 | 2.3K | 94,150 | D | ↗ |
| 2024-11-22 | Lucera Erick | Director | D-Return | D | Stock Options (Right to buy) | 45,000 | 1.53 | 68.9K | 0 | D | ↗ |
| 2024-11-22 | Lisi Steven A. | Director / Officer | D-Return | D | Stock Options (Right to buy) | 200,000 | 5.45 | 1.09M | 0 | D | ↗ |
| 2024-11-22 | Lee Yoori | Director | A-Award | A | Stock Options (Right to buy) | 15,000 | 0.54 | 8.1K | 15,000 | D | ↗ |
| 2024-11-22 | Larson Douglas Quinton | Officer | A-Award | A | Stock Options (Right to buy) | 300,000 | 0.54 | 162.0K | 300,000 | D | ↗ |
| 2024-11-22 | Gaul Michael A. | Officer | D-Return | D | Stock Options (Right to buy) | 40,000 | 5.32 | 212.8K | 0 | D | ↗ |
| 2024-11-22 | Forbes William P | Director | A-Award | A | Stock Options (Right to buy) | 8,000 | 0.54 | 4.3K | 8,000 | D | ↗ |
| 2024-11-22 | Carey Robert | Director | A-Award | A | Stock Options (Right to buy) | 40,000 | 0.54 | 21.6K | 40,000 | D | ↗ |
| 2024-11-22 | BENTSUR RON | Director | D-Return | D | Stock Options (Right to buy) | 30,000 | 6.87 | 206.1K | 0 | D | ↗ |
| 2024-09-27 | Lisi Steven A. | Director / Officer | J-Other | A | Warrants to purchase Common Stock | 3,295,544 | 0.38 | 1.25M | 3,295,544 | D | ↗ |
| 2024-09-27 | Carey Robert | Director | J-Other | A | Warrants to purchase Common Stock | 9,886,633 | 0.38 | 3.75M | 9,886,633 | I | ↗ |
| 2024-09-26 | Lisi Steven A. | Director / Officer | P-Purchase | A | Warrants to purchase Common Stock | 1,982,947 | 0.38 | 752.1K | 1,982,947 | D | ↗ |
| 2024-09-26 | Carey Robert | Director | P-Purchase | A | Pre-funded Warrants to purchase Common Stock | 26,142 | 0.00 | 2.61 | 26,142 | I | ↗ |
| 2024-08-15 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 0.37 | 18.3K | 1,772,785 | — | ↗ |
| 2024-08-14 | Lucera Erick | Director | P-Purchase | A | Common Stock | 39,266 | 0.40 | 15.6K | 43,608 | — | ↗ |
| 2024-08-14 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 100,000 | 0.39 | 38.6K | 1,722,785 | — | ↗ |
| 2024-08-14 | Carey Robert | Director | P-Purchase | A | Common Stock | 100,000 | 0.40 | 39.7K | 3,076,864 | — | ↗ |
| 2024-03-20 | Lucera Erick | Director | A-Award | A | Stock Option (right to buy) | 45,000 | 1.53 | 68.9K | 45,000 | — | ↗ |
| 2024-03-20 | Lisi Steven A. | Director / Officer | A-Award | A | Warrants (right to buy) | 78,314 | 2.25 | 176.2K | 78,314 | — | ↗ |
| 2024-03-20 | Lee Yoori | Director | A-Award | A | Stock Option (right to buy) | 45,000 | 1.53 | 68.9K | 45,000 | — | ↗ |
| 2024-03-20 | Larson Douglas Quinton | Officer | A-Award | A | Warrants (right to buy) | 12,048 | 2.25 | 27.1K | 12,048 | — | ↗ |
| 2024-03-20 | Gaul Michael A. | Officer | A-Award | A | Stock Option (right to buy) | 350,000 | 1.53 | 535.5K | 350,000 | — | ↗ |
| 2024-03-20 | Forbes William P | Director | A-Award | A | Stock Option (right to buy) | 45,000 | 1.53 | 68.9K | 45,000 | — | ↗ |
| 2024-03-20 | Carey Robert | Director | A-Award | A | Warrants (right to buy) | 602,410 | 2.25 | 1.36M | 602,410 | — | ↗ |
| 2024-03-20 | BENTSUR RON | Director | A-Award | A | Stock Option (right to buy) | 45,000 | 1.53 | 68.9K | 45,000 | — | ↗ |
| 2024-03-20 | Avniel Amir | Director / Officer | A-Award | A | Stock Option (right to buy) | 400,000 | 1.53 | 612.0K | 400,000 | — | ↗ |
| 2023-12-28 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 11,267 | 2.06 | 23.2K | 685,760 | — | ↗ |
| 2023-12-27 | Myers Jeff Lynn | Officer | S-Sale | D | Common Stock | 3,423 | 2.21 | 7.6K | 46,577 | — | ↗ |
| 2023-12-18 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 77,775 | 1.63 | 126.8K | 1,536,471 | — | ↗ |
| 2023-12-18 | Carey Robert | Director | P-Purchase | A | Common Stock | 1,200,000 | 1.64 | 1.96M | 2,374,454 | — | ↗ |
| 2023-11-16 | Gaul Michael A. | Officer | P-Purchase | A | Common Stock | 10,000 | 1.77 | 17.7K | 88,150 | — | ↗ |
| 2023-08-28 | Carey Robert | Director | P-Purchase | A | Common Stock | 250,000 | 2.70 | 673.8K | 1,225,160 | — | ↗ |
| 2023-08-21 | Carey Robert | Director | P-Purchase | A | Common Stock | 75,050 | 2.76 | 207.5K | 975,160 | — | ↗ |
| 2023-08-18 | Carey Robert | Director | P-Purchase | A | Common Stock | 13,614 | 2.64 | 35.9K | 900,110 | — | ↗ |
| 2023-06-30 | Gaul Michael A. | Officer | P-Purchase | A | Common Stock | 5,000 | 4.51 | 22.6K | 78,150 | — | ↗ |
| 2023-03-31 | Forbes William P | Director | P-Purchase | A | Common Stock | 5,000 | 6.67 | 33.4K | 14,855 | — | ↗ |
| 2023-03-31 | Carey Robert | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-03-30 | Carey Robert | Director | P-Purchase | A | Common Stock | 10,000 | 6.45 | 64.5K | 886,496 | — | ↗ |
| 2023-03-29 | Lucera Erick | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 6.28 | 251.2K | 40,000 | — | ↗ |
| 2023-03-29 | Lisi Steven A. | Director / Officer | A-Award | A | Stock Option (right to buy) | 800,000 | 6.28 | 5.02M | 800,000 | — | ↗ |
| 2023-03-29 | Lee Yoori | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 6.28 | 251.2K | 40,000 | — | ↗ |
| 2023-03-29 | Larson Douglas Quinton | Officer | A-Award | A | Stock Option (right to buy) | 120,000 | 6.28 | 753.6K | 120,000 | — | ↗ |
| 2023-03-29 | Gaul Michael A. | Officer | A-Award | A | Stock Option (right to buy) | 170,000 | 6.28 | 1.07M | 170,000 | — | ↗ |
| 2023-03-29 | Forbes William P | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 6.28 | 251.2K | 40,000 | — | ↗ |
| 2023-03-29 | Carey Robert | Director | P-Purchase | A | Common Stock | 10,000 | 6.30 | 63.0K | 876,496 | — | ↗ |
| 2023-03-29 | Avniel Amir | Director / Officer | A-Award | A | Stock Option (right to buy) | 80,000 | 6.28 | 502.4K | 80,000 | — | ↗ |
| 2023-03-28 | Lee Yoori | Director | P-Purchase | A | Common Stock | 3,115 | 6.34 | 19.7K | 12,654 | — | ↗ |
| 2023-03-27 | Myers Jeff Lynn | Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 50,000 | — | ↗ |
| 2023-03-24 | Gaul Michael A. | Officer | P-Purchase | A | Common Stock | 1,000 | 6.15 | 6.2K | 73,150 | — | ↗ |
| 2023-03-20 | BENTSUR RON | Director | P-Purchase | A | Common Stock | 2,300 | 6.48 | 14.9K | 144,736 | — | ↗ |
| 2023-03-17 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 6.46 | 64.6K | 1,458,696 | — | ↗ |
| 2023-03-17 | Forbes William P | Director | P-Purchase | A | Common Stock | 5,000 | 6.46 | 32.3K | 9,855 | — | ↗ |
| 2023-03-16 | Lucera Erick | Director | P-Purchase | A | Common Stock | 2,000 | 6.82 | 13.6K | 4,342 | — | ↗ |
| 2023-03-14 | Carey Robert | Director | P-Purchase | A | Common Stock | 10,000 | 6.85 | 68.5K | 866,496 | — | ↗ |
| 2023-03-13 | Carey Robert | Director | P-Purchase | A | Common Stock | 4,173 | 6.15 | 25.7K | 856,496 | — | ↗ |
| 2023-03-13 | Avniel Amir | Director / Officer | P-Purchase | A | Common Stock | 1,000 | 6.40 | 6.4K | 457,027 | — | ↗ |
| 2023-03-08 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 5.89 | 29.4K | 1,447,849 | — | ↗ |
| 2023-03-08 | Carey Robert | Director | P-Purchase | A | Common Stock | 10,000 | 5.95 | 59.5K | 852,323 | — | ↗ |
| 2023-03-07 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 45,000 | 5.98 | 268.9K | 1,442,849 | — | ↗ |
| 2023-03-07 | Gaul Michael A. | Officer | P-Purchase | A | Common Stock | 8,000 | 5.86 | 46.9K | 72,150 | — | ↗ |
| 2023-02-16 | Lisi Steven A. | Director / Officer | S-Sale | D | Common Stock | 48,596 | 6.10 | 296.4K | 1,397,849 | — | ↗ |
| 2022-12-07 | Carey Robert | Director | P-Purchase | A | Common Stock | 20,000 | 5.75 | 115.0K | 842,323 | — | ↗ |
| 2022-11-29 | Carey Robert | Director | P-Purchase | A | Common Stock | 15,000 | 5.75 | 86.2K | 822,323 | — | ↗ |
| 2022-11-28 | Carey Robert | Director | P-Purchase | A | Common Stock | 15,000 | 5.75 | 86.2K | 807,323 | — | ↗ |
| 2022-11-18 | Carey Robert | Director | P-Purchase | A | Common Stock | 20,000 | 5.80 | 116.0K | 792,323 | — | ↗ |
| 2022-11-17 | Carey Robert | Director | P-Purchase | A | Common Stock | 20,000 | 5.90 | 118.0K | 772,323 | — | ↗ |
| 2022-11-16 | Carey Robert | Director | P-Purchase | A | Common Stock | 10,000 | 6.00 | 60.0K | 752,323 | — | ↗ |
| 2022-08-22 | Gaul Michael A. | Officer | P-Purchase | A | Common Stock | 2,000 | 9.42 | 18.8K | 64,150 | — | ↗ |
| 2022-07-01 | Gaul Michael A. | Officer | — | D | Stock Option (right to buy) | 10,000 | 5.32 | 53.2K | 0 | — | ↗ |
| 2022-06-30 | Lisi Steven A. | Officer | P-Purchase | A | Common Stock | 73,000 | 6.63 | 483.7K | 1,446,445 | — | ↗ |
| 2022-06-30 | Carey Robert | Director | P-Purchase | A | Common Stock | 175,000 | 6.45 | 1.13M | 742,323 | — | ↗ |
| 2022-06-30 | BENTSUR RON | Director | S-Sale | D | Common Stock | 40,000 | 6.53 | 261.1K | 142,436 | — | ↗ |
| 2022-06-30 | Avniel Amir | Officer | S-Sale | D | Common Stock | 65,500 | 6.50 | 426.0K | 408,027 | — | ↗ |
| 2022-04-05 | Carey Robert | Director | P-Purchase | A | Common Stock | 20,000 | 6.71 | 134.2K | 567,323 | — | ↗ |
| 2022-03-24 | Carey Robert | Director | P-Purchase | A | Common Stock | 22,500 | 6.65 | 149.6K | 547,323 | — | ↗ |
| 2022-03-17 | Carey Robert | Director | P-Purchase | A | Common Stock | 20,000 | 6.75 | 135.0K | 521,138 | — | ↗ |
| 2022-03-03 | Lucera Erick | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-03-03 | Lisi Steven A. | Officer | A-Award | A | Common Stock | 140,000 | 0.00 | — | 1,373,445 | — | ↗ |
| 2022-03-03 | Lee Yoori | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 6.87 | 206.1K | 30,000 | — | ↗ |
| 2022-03-03 | Larson Douglas Quinton | Officer | A-Award | A | Stock Option (right to buy) | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-03-03 | Forbes William P | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-03-03 | Carey Robert | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 0.00 | — | 30,000 | — | ↗ |
| 2022-03-03 | BENTSUR RON | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 6.87 | 206.1K | 30,000 | — | ↗ |
| 2022-03-03 | Avniel Amir | Officer | A-Award | A | Stock Option (right to buy) | 140,000 | 0.00 | — | 140,000 | — | ↗ |
| 2022-01-12 | Lisi Steven A. | Director / Officer | M-Exempt | A | Common Stock | 83,334 | 3.66 | 305.0K | 1,233,445 | — | ↗ |
| 2021-12-29 | Lisi Steven A. | Director / Officer | S-Sale | D | Common Stock | 21,376 | 9.53 | 203.8K | 1,150,111 | — | ↗ |
| 2021-12-22 | Carey Robert | Director | P-Purchase | A | Common Stock | 10,000 | 9.50 | 95.0K | 518,418 | — | ↗ |
| 2021-12-10 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 40,000 | 8.53 | 341.2K | 1,171,487 | — | ↗ |
| 2021-12-01 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 32,675 | 13.72 | 448.3K | 403,527 | — | ↗ |
| 2021-11-24 | BENTSUR RON | Director | S-Sale | D | Common Stock | 31,000 | 13.44 | 416.6K | 188,900 | — | ↗ |
| 2021-11-23 | Carey Robert | Director | P-Purchase | A | Common Stock | 5,000 | 12.35 | 61.8K | 508,418 | — | ↗ |
| 2021-11-23 | Avniel Amir | Director / Officer | M-Exempt | A | Common Stock | 43,334 | 3.66 | 158.6K | 446,861 | — | ↗ |
| 2021-11-22 | Carey Robert | Director | P-Purchase | A | Common Stock | 10,000 | 12.05 | 120.5K | 503,418 | — | ↗ |
| 2021-11-22 | BENTSUR RON | Director | M-Exempt | A | Common Stock | 50,000 | 3.66 | 183.0K | 232,436 | — | ↗ |
| 2021-11-19 | Carey Robert | Director | P-Purchase | A | Common Stock | 12,000 | 14.10 | 169.2K | 493,418 | — | ↗ |
| 2021-10-05 | Lisi Steven A. | Director / Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 1,131,487 | — | ↗ |
| 2021-10-05 | Avniel Amir | Director / Officer | A-Award | A | Common Stock | 50,000 | 0.00 | — | 403,527 | — | ↗ |
| 2021-09-01 | Larson Douglas Quinton | Officer | A-Award | A | Stock Option (right to buy) | 75,000 | 10.68 | 801.0K | 75,000 | — | ↗ |
| 2021-08-13 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 7.85 | 196.3K | 1,031,487 | — | ↗ |
| 2021-06-17 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 25,000 | 5.36 | 134.0K | 1,006,487 | — | ↗ |
| 2021-06-17 | Carey Robert | Director | P-Purchase | A | Common Stock | 350,000 | 5.36 | 1.88M | 481,418 | — | ↗ |
| 2021-06-16 | BECK DOUGLAS | Officer | P-Purchase | A | Common Stock | 1,000 | 5.38 | 5.4K | 22,460 | — | ↗ |
| 2021-03-31 | Carey Robert | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-03-04 | Lucera Erick | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 5.45 | 136.3K | 25,000 | — | ↗ |
| 2021-03-04 | Lisi Steven A. | Director / Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 5.45 | 1.09M | 200,000 | — | ↗ |
| 2021-03-04 | Lee Yoori | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 5.45 | 136.3K | 25,000 | — | ↗ |
| 2021-03-04 | Forbes William P | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 5.45 | 136.3K | 25,000 | — | ↗ |
| 2021-03-04 | Carey Robert | Director | P-Purchase | A | Common Stock | 17,000 | 5.70 | 96.9K | 131,418 | — | ↗ |
| 2021-03-04 | BENTSUR RON | Director | A-Award | A | Stock Option (right to buy) | 25,000 | 5.45 | 136.3K | 25,000 | — | ↗ |
| 2021-03-04 | BECK DOUGLAS | Officer | A-Award | A | Stock Option (right to buy) | 25,000 | 5.45 | 136.3K | 25,000 | — | ↗ |
| 2021-03-04 | Avniel Amir | Director / Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 5.45 | 545.0K | 100,000 | — | ↗ |
| 2021-02-18 | Carey Robert | Director | P-Purchase | A | Common Stock | 15,000 | 6.67 | 100.1K | 114,418 | — | ↗ |
| 2021-02-16 | Lucera Erick | Director | M-Exempt | A | Common Stock | 1,171 | 4.25 | 5.0K | 2,342 | — | ↗ |
| 2021-02-14 | Avniel Amir | Director / Officer | M-Exempt | D | Tranche B Warrant (Right to Buy) | 2,342 | 4.25 | 10.0K | 0 | — | ↗ |
| 2021-02-12 | BENTSUR RON | Director | M-Exempt | A | Common Stock | 23,419 | 4.25 | 99.5K | 205,855 | — | ↗ |
| 2021-02-11 | BENTSUR RON | Director | S-Sale | D | Common Stock | 1,500 | 6.28 | 9.4K | 182,436 | — | ↗ |
| 2021-02-10 | Lisi Steven A. | Director / Officer | M-Exempt | D | Tranche B Warrant (right to buy) | 117,112 | 4.25 | 497.7K | 0 | — | ↗ |
| 2021-01-21 | Lee Yoori | Director | M-Exempt | D | Tranche B Warrant (Right to Buy) | 2,342 | 4.25 | 10.0K | 0 | — | ↗ |
| 2021-01-04 | Lisi Steven A. | Director / Officer | A-Award | A | Common Stock | 5,500 | 0.00 | — | 934,763 | — | ↗ |
| 2021-01-04 | Avniel Amir | Director / Officer | A-Award | A | Common Stock | 5,300 | 0.00 | — | 351,185 | — | ↗ |
| 2021-01-02 | BENTSUR RON | Director | S-Sale | D | Common Stock | 5,700 | 5.89 | 33.6K | 183,936 | — | ↗ |
| 2020-12-31 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 38,500 | 5.28 | 203.3K | 929 | — | ↗ |
| 2020-12-31 | BECK DOUGLAS | Officer | P-Purchase | A | Common Stock | 3,000 | 5.28 | 15.8K | 21,460 | — | ↗ |
| 2020-12-23 | Avniel Amir | Director / Officer | A-Award | D | Common Stock | 19,100 | 5.28 | 100.8K | 345,885 | — | ↗ |
| 2020-09-24 | BECK DOUGLAS | Officer | P-Purchase | A | Common Stock | 3,000 | 4.88 | 14.6K | 18,460 | — | ↗ |
| 2020-08-25 | BENTSUR RON | Director | S-Sale | D | Common Stock | 1,580 | 5.95 | 9.4K | 189,636 | — | ↗ |
| 2020-08-25 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 3,187 | 5.97 | 19.0K | 326,785 | — | ↗ |
| 2020-08-24 | Carey Robert | Director | P-Purchase | A | Common Stock | 10,000 | 5.70 | 57.0K | 99,418 | — | ↗ |
| 2020-08-24 | BENTSUR RON | Director | S-Sale | D | Common Stock | 3,889 | 5.68 | 22.1K | 191,216 | — | ↗ |
| 2020-08-24 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 7,778 | 5.68 | 44.2K | 329,972 | — | ↗ |
| 2020-08-21 | BENTSUR RON | Director | S-Sale | D | Common Stock | 3,246 | 6.05 | 19.7K | 195,105 | — | ↗ |
| 2020-08-21 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 6,491 | 6.05 | 39.3K | 337,750 | — | ↗ |
| 2020-08-20 | BENTSUR RON | Director | S-Sale | D | Common Stock | 3,778 | 6.29 | 23.8K | 198,351 | — | ↗ |
| 2020-08-20 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 7,555 | 6.29 | 47.6K | 344,241 | — | ↗ |
| 2020-08-19 | BENTSUR RON | Director | S-Sale | D | Common Stock | 6,533 | 6.32 | 41.3K | 202,129 | — | ↗ |
| 2020-08-19 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 13,067 | 6.32 | 82.5K | 351,796 | — | ↗ |
| 2020-08-18 | BENTSUR RON | Director | S-Sale | D | Common Stock | 4,578 | 5.83 | 26.7K | 208,662 | — | ↗ |
| 2020-08-18 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 9,155 | 5.83 | 53.4K | 364,863 | — | ↗ |
| 2020-08-17 | BENTSUR RON | Director | S-Sale | D | Common Stock | 4,413 | 5.72 | 25.2K | 213,240 | — | ↗ |
| 2020-08-17 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 8,827 | 5.72 | 50.5K | 374,018 | — | ↗ |
| 2020-08-14 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 5.55 | 110.9K | 890,763 | — | ↗ |
| 2020-08-14 | Carey Robert | Director | P-Purchase | A | Common Stock | 10,000 | 5.50 | 55.0K | 39,418 | — | ↗ |
| 2020-08-14 | BENTSUR RON | Director | S-Sale | D | Common Stock | 6,680 | 5.53 | 36.9K | 217,653 | — | ↗ |
| 2020-08-14 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 13,364 | 5.52 | 73.7K | 382,845 | — | ↗ |
| 2020-08-13 | Carey Robert | Director | P-Purchase | A | Common Stock | 5,000 | 5.30 | 26.5K | 29,418 | — | ↗ |
| 2020-08-13 | BENTSUR RON | Director | S-Sale | D | Common Stock | 4,088 | 5.50 | 22.5K | 224,333 | — | ↗ |
| 2020-08-13 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 8,179 | 5.50 | 45.0K | 396,209 | — | ↗ |
| 2020-08-12 | BENTSUR RON | Director | S-Sale | D | Common Stock | 4,689 | 5.30 | 24.8K | 228,421 | — | ↗ |
| 2020-08-12 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 9,378 | 5.30 | 49.7K | 404,388 | — | ↗ |
| 2020-08-11 | BENTSUR RON | Director | S-Sale | D | Common Stock | 3,910 | 5.51 | 21.6K | 233,110 | — | ↗ |
| 2020-08-11 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 7,825 | 5.51 | 43.1K | 413,766 | — | ↗ |
| 2020-08-10 | BENTSUR RON | Director | S-Sale | D | Common Stock | 3,437 | 5.42 | 18.6K | 237,020 | — | ↗ |
| 2020-08-10 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 6,900 | 5.42 | 37.4K | 421,591 | — | ↗ |
| 2020-08-07 | BENTSUR RON | Director | S-Sale | D | Common Stock | 10,222 | 5.35 | 54.7K | 245,374 | — | ↗ |
| 2020-08-07 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 20,493 | 5.35 | 109.6K | 438,391 | — | ↗ |
| 2020-08-06 | BENTSUR RON | Director | S-Sale | D | Common Stock | 6,192 | 5.94 | 36.8K | 255,596 | — | ↗ |
| 2020-08-06 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 12,391 | 5.94 | 73.6K | 458,884 | — | ↗ |
| 2020-08-05 | BENTSUR RON | Director | S-Sale | D | Common Stock | 3,619 | 6.16 | 22.3K | 261,788 | — | ↗ |
| 2020-08-05 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 7,233 | 6.15 | 44.5K | 471,275 | — | ↗ |
| 2020-08-04 | BENTSUR RON | Director | S-Sale | D | Common Stock | 3,649 | 6.13 | 22.4K | 265,407 | — | ↗ |
| 2020-08-04 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 7,300 | 6.13 | 44.7K | 478,508 | — | ↗ |
| 2020-08-03 | BENTSUR RON | Director | S-Sale | D | Common Stock | 3,814 | 6.16 | 23.5K | 269,056 | — | ↗ |
| 2020-08-03 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 7,600 | 6.16 | 46.8K | 485,808 | — | ↗ |
| 2020-07-31 | BENTSUR RON | Director | S-Sale | D | Common Stock | 2,868 | 6.27 | 18.0K | 272,870 | — | ↗ |
| 2020-07-31 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 5,800 | 6.26 | 36.3K | 493,408 | — | ↗ |
| 2020-07-30 | BENTSUR RON | Director | S-Sale | D | Common Stock | 3,418 | 6.26 | 21.4K | 275,738 | — | ↗ |
| 2020-07-30 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 6,800 | 6.26 | 42.6K | 499,208 | — | ↗ |
| 2020-07-29 | BENTSUR RON | Director | S-Sale | D | Common Stock | 2,516 | 6.20 | 15.6K | 280,983 | — | ↗ |
| 2020-07-29 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 2,101 | 6.10 | 12.8K | 507,441 | — | ↗ |
| 2020-07-28 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 5,000 | 6.20 | 31.0K | 509,542 | — | ↗ |
| 2020-07-27 | BENTSUR RON | Director | S-Sale | D | Common Stock | 4,917 | 6.27 | 30.8K | 278,582 | — | ↗ |
| 2020-07-27 | Avniel Amir | Director / Officer | S-Sale | D | Common Stock | 9,900 | 6.26 | 62.0K | 504,642 | — | ↗ |
| 2020-06-25 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 35,000 | 7.45 | 260.8K | 870,763 | — | ↗ |
| 2019-12-30 | Lisi Steven A. | Director / Officer | S-Sale | D | Common Stock | 5,992 | 4.43 | 26.6K | 815,763 | — | ↗ |
| 2019-12-12 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 190,437 | 3.66 | 697.0K | 821,755 | — | ↗ |
| 2019-12-12 | Avniel Amir | Director / Officer | P-Purchase | A | Common Stock | 8,152 | 3.68 | 30.0K | 470,476 | — | ↗ |
| 2019-11-15 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 4.09 | 40.9K | 631,318 | — | ↗ |
| 2019-11-14 | Lisi Steven A. | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 4.04 | 40.4K | 621,318 | — | ↗ |
Executive team
Top executives
Shares Outstanding
5.07M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Steven A. Lisi. Chief Executive Officer and Chairman of the Board | 555.0K | — | — | 266.1K | — | — | 1.38M | 19.34% | ↗ |
| 2 | 2025 | Amir Avniel President, Chief Business Officer and Director | 412.7K | — | — | 110.1K | — | — | 935.4K | 11.77% | ↗ |
| 3 | 2025 | Michael Gaul Chief Operating Officer | 372.7K | — | — | 92.2K | — | — | 837.5K | 11.01% | ↗ |
| 4 | 2025 | Douglas Larson Chief Financial Officer | 324.4K | — | — | 80.9K | — | — | 729.7K | 11.08% | ↗ |
| 5 | 2024 | Steven A. Lisi. Chief Executive Officer and Chairman of the Board | 650.0K | — | — | 1.08M | — | — | 2.38M | 45.45% | ↗ |
| 6 | 2024 | Amir Avniel President, Chief Business Officer and Director | 496.0K | — | — | 456.0K | — | — | 1.45M | 31.49% | ↗ |
| 7 | 2024 | Michael Gaul Chief Operating Officer | 400.0K | — | — | 399.0K | — | — | 1.20M | 33.28% | ↗ |
| 8 | 2024 | Douglas Larson Chief Financial Officer | 350.0K | — | — | 342.0K | — | — | 1.04M | 32.82% | ↗ |
| 9 | 2023 | Steven A. Lisi. Chief Executive Officer and Chairman of the Board | 650.0K | — | — | 6.23M | — | — | 7.53M | 82.73% | ↗ |
| 10 | 2023 | Amir Avniel President, Chief Business Officer and Director | 400.0K | — | — | 1.29M | — | — | 3.60M | 35.93% | ↗ |
| 11 | 2023 | Michael Gaul Chief Operating Officer | 350.0K | — | — | 782.0K | — | — | 1.48M | 52.77% | ↗ |
| 12 | 2022 | Steven A. Lisi. Chief Executive Officer and Chairman of the Board | 450.0K | — | — | 4.01M | — | — | 6.91M | 58.03% | ↗ |
| 13 | 2022 | Amir Avniel President, Chief Business Officer and Director | 400.0K | — | — | 1.75M | — | — | 3.55M | 49.27% | ↗ |
| 14 | 2022 | Michael Gaul Chief Operating Officer | 250.0K | — | — | 360.5K | — | — | 1.20M | 30.13% | ↗ |
| 15 | 2022 | Douglas Larson Chief Financial Officer | 160.4K | — | 103.1K | 755.8K | — | — | 1.02M | 84.26% | ↗ |
| 16 | 2022 | Douglas Beck, CPA Previous Chief Financial Officer | 291.7K | — | 26.0K | — | — | — | 317.6K | 8.18% | ↗ |
| 17 | 2021 | Steven A. Lisi. Chief Executive Officer and Chairman of the Board | 450.0K | — | — | 1.09M | — | — | 1.54M | 70.74% | ↗ |
| 18 | 2021 | Amir Avniel President, Chief Business Officer and Director | 400.0K | — | — | 544.0K | — | — | 944.0K | 57.63% | ↗ |
| 19 | 2021 | Amir Avniel President, Chief Operating Officer and Director | 400.0K | — | — | 544.0K | — | — | 944.0K | 57.63% | ↗ |
| 20 | 2021 | Douglas Beck, CPA Chief Financial Officer | 250.0K | — | — | 136.0K | — | — | 386.0K | 35.23% | ↗ |
| 21 | 2021 | Douglas Beck, CPA Previous Chief Financial Officer | 250.0K | — | — | 136.0K | — | — | 386.0K | 35.23% | ↗ |
| 22 | 2020 | Steven A. Lisi Chief Executive Officer and Chairman of the Board | 450.0K | — | 546.5K | 272.3K | — | — | 1.27M | 64.53% | ↗ |
| 23 | 2020 | Steven A. Lisi. Chief Executive Officer and Chairman of the Board | 450.0K | — | 546.5K | 272.3K | — | — | 1.27M | 64.53% | ↗ |
| 24 | 2020 | Amir Avniel President, Chief Operating Officer and Director | 400.0K | — | 264.1K | 155.6K | — | — | 819.7K | 51.20% | ↗ |
| 25 | 2020 | Douglas Beck, CPA Chief Financial Officer | 250.0K | — | 78.5K | 77.8K | — | — | 406.3K | 38.46% | ↗ |
| 26 | 2019 | Steven A. Lisi. Chief Executive Officer and Chairman of the Board | 450.0K | — | 462.0K | 1.93M | — | — | 2.84M | 84.15% | ↗ |
| 27 | 2019 | Steven A. Lisi Chief Executive Officer and Chairman of the Board | 450.0K | — | 462.0K | 1.93M | — | — | 2.84M | 84.15% | ↗ |
| 28 | 2019 | Amir Avniel President, Chief Operating Officer and Director | 400.0K | — | 220.2K | 727.8K | — | — | 1.35M | 70.33% | ↗ |
| 29 | 2019 | Hai Aviv Adam Newman Inhouse Counsel | 250.0K | — | 229.5K | 492.5K | — | — | 972.0K | 74.28% | ↗ |
| 30 | 2019 | Duncan Fatkin | 104.2K | — | — | 312.9K | — | — | 417.1K | 75.03% | ↗ |
| 31 | 2019 | Douglas Beck, CPA Chief Financial Officer | 104.2K | — | — | 300.0K | — | — | 404.2K | 74.23% | ↗ |
| 32 | 2018 | Steven A. Lisi. Chief Executive Officer and Chairman of the Board | 130.0K | — | — | — | — | — | 130.0K | 0.00% | ↗ |
| 33 | 2018 | Amir Avniel President, Chief Operating Officer and Director | 85.0K | — | 27.0K | — | — | — | 112.0K | 24.11% | ↗ |
| 34 | 2018 | Hai Aviv Adam Newman Inhouse Counsel | 62.5K | — | — | — | — | — | 62.5K | 0.00% | ↗ |
| 35 | 2017 | Amir Avniel President, Chief Operating Officer and Director | 286.0K | 50.0K | 89.0K | — | — | — | 425.0K | 20.94% | ↗ |
| 36 | 2017 | Douglas Beck, CPA Chief Financial Officer | 160.0K | — | — | 39.0K | — | — | 199.0K | 19.60% | ↗ |
| 37 | 2017 | Steven A. Lisi. Chief Executive Officer and Chairman of the Board | 163.0K | — | — | — | — | — | 163.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Robert Scott Goodman | CEO & Director | 555.0K | male |
| Amir Avniel | Chief Executive Officer of NeuroNOS | 412.7K | male |
| Michael A. Gaul | Chief Operating Officer | 372.7K | male |
| Daniel J. Moorhead | Chief Financial Officer | 324.4K | male |
| Adam Newman | Corporate Secretary | 250.0K | male |
| John Jett | Head of Research & Clinical Development | — | — |
| Denton Drewell | Principal Accounting Officer & Controller | — | male |
| Andrew R. Colin | Senior Medical Director Global Clinical Leadership & Member of Scientific Advisory Board | — | — |
ESG Rating
ESG Score History MEDICAL - DEVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for XAIR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
